Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Nishida

Showing results (101-110 of 164) with videos related to

Pageof 17
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2020
Favorable Effect of Cytomegalovirus Reactivation on Outcomes in Cord Blood Transplant and Its Differences Among Disease Risk or TypeHisayuki Yokoyama, Katsuto Takenaka, Tetsuya Nishida, et al.
British Journal of Haematology|March 23, 2026
Significant clinical impact of immunosuppressive therapy termination after allogeneic haematopoietic stem cell transplantationShigeo Fuji, Akihiro Ohmoto, Yuho Najima, et al.
Blood|August 13, 2010
The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptorMichael Hudecek, Thomas M Schmitt, Sivasubramanian Baskar, et al.
Blood Neoplasia|October 27, 2025
Analyses of transplantation outcomes for adult patients with mixed-phenotype acute leukemiaTomoyasu Jo, Tadakazu Kondo, Shohei Mizuno, et al.
Bone Marrow Transplantation|May 7, 2024
Prognostic impact of the conditioning intensity on outcomes after allogeneic transplantation for MDS with low blasts: a nationwide retrospective study by the adult MDS working group of the Japan Society for Transplantation and Cellular TherapyHidehiro Itonaga, Yasushi Miyazaki, Machiko Fujioka, et al.
Transplantation and Cellular Therapy|September 5, 2025
Risk Stratification Using DIPSS and Splenomegaly in Myelofibrosis Treated with Pre-Transplant JAK inhibitorsYosuke Okada, Kazuki Sakatoku, Shuichi Shirane, et al.
Cytotherapy|November 6, 2024
Outcome of donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation in relapsed myelodysplastic syndromeAtsushi Marumo, Yasunobu Nagata, Machiko Fujioka, et al.
Bone Marrow Transplantation|December 16, 2023
Analysis of risk factors for fatal renal complications after allogeneic hematopoietic cell transplantationRyu Yanagisawa, Hiroaki Koyama, Kimikazu Yakushijin, et al.
Bone Marrow Transplantation|February 10, 2024
Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantationRyusuke Yamamoto, Nobuhiro Hiramoto, Ayumi Fujimoto, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 14, 2026
Bidirectional associations between bacteremia and cytomegalovirus infection after allogeneic hematopoietic cell transplantation: JSTCT Transplant Complications Working GroupShun-Ichi Kimura, Kazuki Yoshimura, Hideki Nakasone, et al.
Pageof 17

Showing results (101-110 of 164) with videos related to

Sort By:
Pageof 17
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2020
Favorable Effect of Cytomegalovirus Reactivation on Outcomes in Cord Blood Transplant and Its Differences Among Disease Risk or TypeHisayuki Yokoyama, Katsuto Takenaka, Tetsuya Nishida, et al.
British Journal of Haematology|March 23, 2026
Significant clinical impact of immunosuppressive therapy termination after allogeneic haematopoietic stem cell transplantationShigeo Fuji, Akihiro Ohmoto, Yuho Najima, et al.
Blood|August 13, 2010
The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptorMichael Hudecek, Thomas M Schmitt, Sivasubramanian Baskar, et al.
Blood Neoplasia|October 27, 2025
Analyses of transplantation outcomes for adult patients with mixed-phenotype acute leukemiaTomoyasu Jo, Tadakazu Kondo, Shohei Mizuno, et al.
Bone Marrow Transplantation|May 7, 2024
Prognostic impact of the conditioning intensity on outcomes after allogeneic transplantation for MDS with low blasts: a nationwide retrospective study by the adult MDS working group of the Japan Society for Transplantation and Cellular TherapyHidehiro Itonaga, Yasushi Miyazaki, Machiko Fujioka, et al.
Transplantation and Cellular Therapy|September 5, 2025
Risk Stratification Using DIPSS and Splenomegaly in Myelofibrosis Treated with Pre-Transplant JAK inhibitorsYosuke Okada, Kazuki Sakatoku, Shuichi Shirane, et al.
Cytotherapy|November 6, 2024
Outcome of donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation in relapsed myelodysplastic syndromeAtsushi Marumo, Yasunobu Nagata, Machiko Fujioka, et al.
Bone Marrow Transplantation|December 16, 2023
Analysis of risk factors for fatal renal complications after allogeneic hematopoietic cell transplantationRyu Yanagisawa, Hiroaki Koyama, Kimikazu Yakushijin, et al.
Bone Marrow Transplantation|February 10, 2024
Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantationRyusuke Yamamoto, Nobuhiro Hiramoto, Ayumi Fujimoto, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 14, 2026
Bidirectional associations between bacteremia and cytomegalovirus infection after allogeneic hematopoietic cell transplantation: JSTCT Transplant Complications Working GroupShun-Ichi Kimura, Kazuki Yoshimura, Hideki Nakasone, et al.
Pageof 17